Showing results (91-100 of 335) with videos related to
Sort By:
Pageof 34
Therapeutic Advances in Medical Oncology|June 16, 2020
Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)Tadaaki Yamada, Junji Uchino, Yusuke Chihara, et al.Translational Lung Cancer Research|September 27, 2019
Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study)Masahiro Iwasaku, Junji Uchino, Tadaaki Yamada, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 28, 2018
Predictive factors for taxane acute pain syndrome determined by ordered logistic regression analysisYuko Kanbayashi, Kouichi Sakaguchi, Katsuhiko Nakatsukasa, et al.Journal of Clinical Medicine|May 10, 2020
Immune Checkpoint Inhibitors for Lung Cancer Treatment: A ReviewKeisuke Onoi, Yusuke Chihara, Junji Uchino, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 13, 2016
The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II studyMasaki Fujita, Takemasa Matsumoto, Yuuichi Inoue, et al.Anticancer Research|April 9, 2005
Gene transfer of inhibitor kappaB in human lung cancer cell line NCI-H460 inhibits tumorigenesis and angiogenesis in vivoJian Ni, Koichi Takayama, Naoko Inoshima, et al.Cancers|March 2, 2019
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human PatientsTatsuya Imabayashi, Junji Uchino, Hisayuki Osoreda, et al.Biological & Pharmaceutical Bulletin|December 22, 2024
Cynaropicrin Increases [Ca2+]i and Ciliary Beat Frequency in Human Airway Epithelial Cells by Inhibiting SERCANobuhisa Todo, Shigekuni Hosogi, Seikou Nakamura, et al.Molecular Cancer Therapeutics|December 20, 2002
A model system for the design of armed replicating adenoviruses using p53 as a candidate transgeneYosef S Haviv, Koichi Takayama, Joel N Glasgow, et al.Internal Medicine (Tokyo, Japan)|September 15, 2012
Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumorNaoki Kubo, Taishi Harada, Satoshi Anai, et al.Pageof 34